Relatlimab (BMS-986016)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 21:53, 22 March 2022 by Jwarner (talk | contribs) (Jwarner moved page Relatlimab (BMS-986016) to Nivolumab and relatlimab (Opdualag): FDA approval)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Relatlimab_(BMS-986016)&oldid=55315"